Literature DB >> 23324917

Mitral regurgitation in patients with heart failure. Interventional therapies.

V Rudolph1, S Baldus.   

Abstract

Mitral regurgitation (MR) is a common complication in heart failure patients, severely worsening their outcome. Because of the high perioperative risk, mitral valve surgery, which is the standard therapy for MR, is often not offered to these patients. Interventional therapies for mitral valve therapy might therefore constitute a novel therapeutic option particularly in this group. This article gives an overview of the available and evolving interventional strategies for mitral valve repair with a special emphasis on heart failure patients.

Entities:  

Mesh:

Year:  2013        PMID: 23324917     DOI: 10.1007/s00059-012-3748-0

Source DB:  PubMed          Journal:  Herz        ISSN: 0340-9937            Impact factor:   1.443


  41 in total

1.  Mitral annulus flattens in ischemic mitral regurgitation: geometric differences between inferior and anterior myocardial infarction: a real-time 3-dimensional echocardiographic study.

Authors:  Nozomi Watanabe; Yasuo Ogasawara; Yasuko Yamaura; Nozomi Wada; Takahiro Kawamoto; Eiji Toyota; Takashi Akasaka; Kiyoshi Yoshida
Journal:  Circulation       Date:  2005-08-30       Impact factor: 29.690

2.  Acute outcomes of MitraClip therapy for mitral regurgitation in high-surgical-risk patients: emphasis on adverse valve morphology and severe left ventricular dysfunction.

Authors:  Olaf Franzen; Stephan Baldus; Volker Rudolph; Sven Meyer; Malgorzata Knap; Dietmar Koschyk; Hendrik Treede; Achim Barmeyer; Joachim Schofer; Angelika Costard-Jäckle; Michael Schlüter; Hermann Reichenspurner; Thomas Meinertz
Journal:  Eur Heart J       Date:  2010-03-10       Impact factor: 29.983

3.  Mitral regurgitation and death while awaiting cardiac transplantation.

Authors:  J B Conti; R M Mills
Journal:  Am J Cardiol       Date:  1993-03-01       Impact factor: 2.778

4.  MitraClip therapy in daily clinical practice: initial results from the German transcatheter mitral valve interventions (TRAMI) registry.

Authors:  Stephan Baldus; Wolfgang Schillinger; Olaf Franzen; Raffi Bekeredjian; Horst Sievert; Joachim Schofer; Karl-Heinz Kuck; Thomas Konorza; Helge Möllmann; Christoph Hehrlein; Taoufik Ouarrak; Jochen Senges; Thomas Meinertz
Journal:  Eur J Heart Fail       Date:  2012-06-08       Impact factor: 15.534

5.  Acute and 12-month results with catheter-based mitral valve leaflet repair: the EVEREST II (Endovascular Valve Edge-to-Edge Repair) High Risk Study.

Authors:  Patrick L Whitlow; Ted Feldman; Wes R Pedersen; D Scott Lim; Robert Kipperman; Richard Smalling; Tanvir Bajwa; Howard C Herrmann; John Lasala; James T Maddux; Murat Tuzcu; Samir Kapadia; Alfredo Trento; Robert J Siegel; Elyse Foster; Donald Glower; Laura Mauri; Saibal Kar
Journal:  J Am Coll Cardiol       Date:  2012-01-10       Impact factor: 24.094

6.  The echocardiographic determinants of functional mitral regurgitation differ in ischemic and non-ischemic cardiomyopathy.

Authors:  Mika Nagasaki; Satoshi Nishimura; Eiji Ohtaki; Hitoshi Kasegawa; Takayoshi Matsumura; Masatoshi Nagayama; Tetsuya Koyanagi; Tetsuya Tohbaru; Kazuhiko Misu; Ryuta Asano; Tetsuya Sumiyoshi; Saichi Hosoda
Journal:  Int J Cardiol       Date:  2006-04-04       Impact factor: 4.164

7.  Acute safety and 30-day outcome after percutaneous edge-to-edge repair of mitral regurgitation in very high-risk patients.

Authors:  Sven T Pleger; Derliz Mereles; Marius Schulz-Schönhagen; Ulrike Krumsdorf; Emmanuel Chorianopoulos; Wolfgang Rottbauer; Hugo A Katus; Raffi Bekeredjian
Journal:  Am J Cardiol       Date:  2011-09-03       Impact factor: 2.778

Review 8.  Chronic ischaemic mitral regurgitation. Current treatment results and new mechanism-based surgical approaches.

Authors:  Wobbe Bouma; Iwan C C van der Horst; Inez J Wijdh-den Hamer; Michiel E Erasmus; Felix Zijlstra; Massimo A Mariani; Tjark Ebels
Journal:  Eur J Cardiothorac Surg       Date:  2009-08-27       Impact factor: 4.191

9.  Guidelines on the management of valvular heart disease (version 2012): the Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS).

Authors:  Alec Vahanian; Ottavio Alfieri; Felicita Andreotti; Manuel J Antunes; Gonzalo Barón-Esquivias; Helmut Baumgartner; Michael Andrew Borger; Thierry P Carrel; Michele De Bonis; Arturo Evangelista; Volkmar Falk; Bernard Lung; Patrizio Lancellotti; Luc Pierard; Susanna Price; Hans-Joachim Schäfers; Gerhard Schuler; Janina Stepinska; Karl Swedberg; Johanna Takkenberg; Ulrich Otto Von Oppell; Stephan Windecker; Jose Luis Zamorano; Marian Zembala
Journal:  Eur J Cardiothorac Surg       Date:  2012-08-25       Impact factor: 4.191

10.  Treatment of functional mitral regurgitation by percutaneous annuloplasty: results of the TITAN Trial.

Authors:  Tomasz Siminiak; Justina C Wu; Michael Haude; Uta C Hoppe; Jerzy Sadowski; Janusz Lipiecki; Jean Fajadet; Amil M Shah; Ted Feldman; David M Kaye; Steven L Goldberg; Wayne C Levy; Scott D Solomon; David G Reuter
Journal:  Eur J Heart Fail       Date:  2012-05-21       Impact factor: 15.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.